David P. Perry, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 40,328 shares at $16.58 ($655K) on 2013-12-06, disclosed to the SEC on 2013-12-09.
Scheduled sale ($655k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.18 | 12,100 | $184K | 28.1% |
| 2 | $15.67 | 2,900 | $45K | 6.9% |
| 3 | $16.58 | 5,200 | $86K | 13.2% |
| 4 | $16.99 | 9,800 | $167K | 25.4% |
| 5 | $16.72 | 10,328 | $173K | 26.4% |
| Total | $16.23 avg | 40,328 |
| $655K |
| 100% |
| Filing → |
| ANAC | SELL | 2014-02-05 | $255K | — | Filing → |
| ANAC | SELL | 2014-01-09 | $1.1M | — | Filing → |